DIFLUPREDNATE

DIFLUPREDNATE was reported 3861 times

DIFLUPREDNATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OCULAR SURFACE STEM CELL TRANSPLANT REJECTION 2 0.2222
1 CORNEAL LACERATION 3 0.1667
2 AQUEOUS FIBRIN 6 0.1176
3 ANTERIOR CHAMBER FIBRIN 11 0.0853
4 AMNIOTIC MEMBRANE GRAFT 2 0.0769
5 INFECTIVE KERATITIS 4 0.0563
6 INFECTIOUS CRYSTALLINE KERATOPATHY 2 0.0541
7 PULMONARY FUNCTION TEST 3 0.0536
8 CONJUNCTIVAL FILTERING BLEB LEAK 2 0.0526
9 FIBRIN 2 0.0465
10 PSEUDOPHAKIA 4 0.0460
11 SCLEROMALACIA 3 0.0435
12 INTRAOCULAR PRESSURE INCREASED 530 0.0414
13 VIRAL UVEITIS 4 0.0412
14 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 3 0.0411
15 RETINAL OCCLUSIVE VASCULITIS 9 0.0402
16 CORNEAL TOXICITY 4 0.0360
17 INFECTIVE SCLERITIS 3 0.0333
18 CORNEAL GRAFT REJECTION 7 0.0333
19 RETINITIS VIRAL 4 0.0331
20 ANTERIOR CHAMBER CELL 21 0.0294
21 TOXIC ANTERIOR SEGMENT SYNDROME 31 0.0284
22 CHORIORETINAL FOLDS 2 0.0282
23 ARTHRITIS FUNGAL 2 0.0278
24 PANOPHTHALMITIS 5 0.0273
25 IDIOPATHIC ORBITAL INFLAMMATION 5 0.0260
26 GRANULOCYTOSIS 5 0.0255
27 VITREAL CELLS 5 0.0248
28 MACULAR CYST 2 0.0238
29 POSTERIOR CAPSULE OPACIFICATION 8 0.0233
30 CYTOMEGALOVIRUS GASTROENTERITIS 5 0.0231
31 INTRAOCULAR PRESSURE TEST ABNORMAL 16 0.0227
32 VITREOUS HAZE 3 0.0196
33 CORNEAL OEDEMA 41 0.0183
34 CORNEAL EPITHELIUM DEFECT 10 0.0172
35 ANTERIOR CHAMBER FLARE 4 0.0172
36 FUSOBACTERIUM INFECTION 2 0.0171
37 HYPOPYON 14 0.0169
38 CONJUNCTIVAL EROSION 2 0.0165
39 ACQUIRED EPIDERMOLYSIS BULLOSA 2 0.0163
40 CORNEAL THINNING 4 0.0156
41 CORNEAL DEFECT 2 0.0152
42 BACTERIAL ENDOPHTHALMITIS 4 0.0150
43 HYPOTONY OF EYE 6 0.0143
44 HLA-B*27 POSITIVE 2 0.0143
45 PERIORBITAL PAIN 12 0.0142
46 CORNEAL TRANSPLANT 11 0.0140
47 CORNEAL SCAR 7 0.0139
48 NECROTISING SCLERITIS 2 0.0138
49 DERMATOCHALASIS 2 0.0136
50 CYTOMEGALOVIRUS OESOPHAGITIS 5 0.0136
51 CATARACT CORTICAL 2 0.0134
52 PRODUCT DROPPER ISSUE 10 0.0127
53 CORNEAL DISORDER 27 0.0123
54 PUNCTATE KERATITIS 11 0.0120
55 CATARACT SUBCAPSULAR 7 0.0115
56 INTRAOCULAR PRESSURE DECREASED 6 0.0114
57 FALSE POSITIVE LABORATORY RESULT 2 0.0108
58 EYE INFECTION STAPHYLOCOCCAL 3 0.0104
59 OCULAR PROCEDURAL COMPLICATION 2 0.0103
60 IRITIS 31 0.0102
61 EYE INFLAMMATION 97 0.0102
62 CORNEAL DYSTROPHY 4 0.0096
63 CORNEAL INFILTRATES 3 0.0096
64 CYSTOID MACULAR OEDEMA 18 0.0095
65 HAEMATOLOGY TEST ABNORMAL 3 0.0093
66 CORNEAL INFECTION 2 0.0092
67 HISTOLOGY ABNORMAL 2 0.0090
68 KL-6 INCREASED 2 0.0088
69 CREST SYNDROME 2 0.0084
70 CORNEAL DEGENERATION 2 0.0083
71 PNEUMONIA HAEMOPHILUS 4 0.0082
72 ENDOPHTHALMITIS 49 0.0082
73 VITRITIS 15 0.0081
74 INTRAOCULAR LENS IMPLANT 4 0.0081
75 GLARE 4 0.0078
76 IRIS ADHESIONS 4 0.0078
77 EYE INFECTION FUNGAL 3 0.0078
78 CATARACT NUCLEAR 5 0.0075
79 STEATOHEPATITIS 4 0.0075
80 CUTIS LAXA 2 0.0074
81 SUPERFICIAL INJURY OF EYE 8 0.0073
82 RETINAL OEDEMA 14 0.0073
83 DISEASE SUSCEPTIBILITY 2 0.0072
84 UVEITIS 98 0.0072
85 CHOROIDAL DETACHMENT 4 0.0072
86 OCULAR HYPERTENSION 14 0.0072
87 OESOPHAGEAL FOOD IMPACTION 4 0.0072
88 CYTOMEGALOVIRUS CHORIORETINITIS 14 0.0072
89 FOREIGN BODY SENSATION IN EYES 45 0.0071
90 DERMATOPHYTOSIS 2 0.0070
91 LENTICULAR OPACITIES 3 0.0069
92 COCCYDYNIA 10 0.0068
93 THERAPY PARTIAL RESPONDER 105 0.0067
94 ANTERIOR CHAMBER INFLAMMATION 4 0.0067
95 CORNEAL DEPOSITS 5 0.0067
96 ECZEMA ASTEATOTIC 3 0.0064
97 DRUG TOLERANCE DECREASED 17 0.0060
98 NON-INFECTIOUS ENDOPHTHALMITIS 5 0.0059
99 CORNEAL ABRASION 8 0.0058
100 INJURY CORNEAL 3 0.0058
101 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 2 0.0056
102 CORNEAL EROSION 3 0.0056
103 ULCERATIVE KERATITIS 15 0.0055
104 RETINAL EXUDATES 5 0.0053
105 RETINAL VASCULITIS 6 0.0050
106 EYELID PAIN 10 0.0049
107 RETINAL ISCHAEMIA 3 0.0049
108 POST PROCEDURAL INFLAMMATION 3 0.0048
109 HYPERPARATHYROIDISM SECONDARY 12 0.0048
110 IRIDOCYCLITIS 15 0.0047
111 OCULAR DISCOMFORT 51 0.0045
112 ACUTE LEFT VENTRICULAR FAILURE 3 0.0045
113 EPISCLERITIS 3 0.0043
114 OPTIC NERVE INJURY 5 0.0043
115 ADENOCARCINOMA GASTRIC 4 0.0043
116 EYE PAIN 243 0.0043
117 SACROILIITIS 8 0.0042
118 BLOOD IRON ABNORMAL 4 0.0041
119 CATARACT OPERATION COMPLICATION 2 0.0039
120 KERATOPATHY 6 0.0038
121 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
122 SKIN BACTERIAL INFECTION 3 0.0037
123 MACULAR HOLE 5 0.0037
124 IRIS DISORDER 2 0.0037
125 NEPHROGENIC ANAEMIA 17 0.0037
126 DYSCHROMATOPSIA 3 0.0036
127 EYE INFECTION BACTERIAL 2 0.0036
128 GLAUCOMA 69 0.0036
129 BODY TINEA 2 0.0036
130 BLINDNESS UNILATERAL 50 0.0035
131 RED BLOOD CELL COUNT ABNORMAL 5 0.0034
132 EYE BURNS 2 0.0034
133 EYE OPERATION 15 0.0033
134 MUSCLE ABSCESS 2 0.0032
135 EYE INFECTION 36 0.0032
136 CORNEAL PERFORATION 2 0.0032
137 VITREOUS FLOATERS 31 0.0032
138 FOREIGN BODY IN EYE 3 0.0031
139 RED BLOOD CELL ABNORMALITY 3 0.0031
140 EYELID RASH 3 0.0031
141 EYE IRRITATION 175 0.0030
142 HERPES OPHTHALMIC 4 0.0030
143 ABNORMAL SENSATION IN EYE 13 0.0030
144 PHOTOPHOBIA 56 0.0030
145 CORNEAL OPACITY 4 0.0029
146 FUSARIUM INFECTION 2 0.0029
147 EYELID IRRITATION 7 0.0028
148 OCULAR TOXICITY 3 0.0027
149 CONJUNCTIVITIS ALLERGIC 4 0.0027
150 CATARACT OPERATION 16 0.0027
151 CATARACT 158 0.0027
152 HUMAN HERPESVIRUS 6 INFECTION 5 0.0026
153 CHROMATOPSIA 2 0.0026
154 RETINAL DETACHMENT 24 0.0026
155 EYE DISCHARGE 27 0.0026
156 STREPTOCOCCAL SEPSIS 3 0.0025
157 MULTIPLE USE OF SINGLE-USE PRODUCT 14 0.0025
158 CARTILAGE ATROPHY 2 0.0025
159 OPTIC ATROPHY 4 0.0025
160 OESOPHAGEAL RUPTURE 2 0.0024
161 HEPATITIS A 2 0.0024
162 OVARIAN CANCER METASTATIC 2 0.0024
163 MACULAR OEDEMA 13 0.0023
164 KERATITIS 7 0.0023
165 HYPOPITUITARISM 4 0.0023
166 CALCINOSIS 5 0.0022
167 VITREOUS HAEMORRHAGE 6 0.0022
168 ESCHERICHIA BACTERAEMIA 5 0.0021
169 HYPERMETROPIA 2 0.0021
170 CONJUNCTIVAL HAEMORRHAGE 8 0.0021
171 NAIL INFECTION 3 0.0021
172 DARK CIRCLES UNDER EYES 3 0.0020
173 RETINAL TEAR 5 0.0020
174 LACRIMATION INCREASED 61 0.0020
175 INSTILLATION SITE PAIN 5 0.0020
176 IMPETIGO 3 0.0020
177 ACQUIRED HAEMOPHILIA 2 0.0020
178 LIPIDS INCREASED 4 0.0020
179 CHOLANGITIS SCLEROSING 4 0.0019
180 EYE ALLERGY 3 0.0019
181 PRODUCT AVAILABILITY ISSUE 44 0.0019
182 PRODUCT PACKAGING DIFFICULT TO OPEN 5 0.0019
183 NASAL INFLAMMATION 2 0.0019
184 HYDROCELE 2 0.0019
185 OCULAR HYPERAEMIA 89 0.0019
186 SCLERITIS 3 0.0019
187 VITREOUS DETACHMENT 4 0.0018
188 BLINDNESS 74 0.0018
189 MENINGITIS 12 0.0018
190 SKIN HYPERTROPHY 5 0.0018
191 HALO VISION 2 0.0018
192 EYE SWELLING 65 0.0017
193 CYTOMEGALOVIRUS COLITIS 4 0.0017
194 CHEMICAL BURN 2 0.0017
195 CATATONIA 9 0.0017
196 APHTHOUS ULCER 13 0.0017
197 REBOUND ACID HYPERSECRETION 5 0.0017
198 EYE INJURY 5 0.0016
199 ESSENTIAL HYPERTENSION 3 0.0016
200 DYSCHEZIA 5 0.0016
201 TRANSPLANT FAILURE 4 0.0016
202 EYE OEDEMA 4 0.0016
203 ENCEPHALITIS 11 0.0016
204 ABDOMINAL INFECTION 4 0.0016
205 INFUSION SITE IRRITATION 2 0.0016
206 RETINAL DISORDER 4 0.0015
207 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
208 PRODUCT CONTAINER ISSUE 13 0.0015
209 ACROCHORDON 2 0.0015
210 LIQUID PRODUCT PHYSICAL ISSUE 11 0.0015
211 EYE HAEMORRHAGE 20 0.0015
212 EYE DISORDER 49 0.0015
213 PRODUCT ADMINISTRATION ERROR 30 0.0015
214 CARBON DIOXIDE INCREASED 2 0.0015
215 ASTHENOPIA 8 0.0015
216 EOSINOPHILIC OESOPHAGITIS 4 0.0014
217 AUDITORY DISORDER 2 0.0014
218 VISION BLURRED 193 0.0014
219 JAW FRACTURE 3 0.0014
220 VISUAL FIELD DEFECT 10 0.0014
221 FAT TISSUE INCREASED 2 0.0014
222 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
223 VENTRICULAR ARRHYTHMIA 5 0.0014
224 AXILLARY PAIN 2 0.0013
225 PEMPHIGOID 10 0.0013
226 END STAGE RENAL DISEASE 24 0.0013
227 PNEUMONIA BACTERIAL 12 0.0013
228 EYELID DISORDER 3 0.0013
229 SINUS PAIN 3 0.0013
230 EYELIDS PRURITUS 4 0.0013
231 BLOOD BLISTER 4 0.0013
232 PRODUCT PHYSICAL CONSISTENCY ISSUE 7 0.0013
233 VISUAL ACUITY REDUCED 42 0.0013
234 RETINAL HAEMORRHAGE 9 0.0013
235 NASAL ULCER 2 0.0013
236 VISUAL IMPAIRMENT 155 0.0012
237 OPTIC NERVE DISORDER 2 0.0012
238 NIGHT BLINDNESS 2 0.0012
239 COLON CANCER METASTATIC 2 0.0012
240 BACTERIAL SEPSIS 4 0.0012
241 BLINDNESS TRANSIENT 9 0.0012
242 DEVICE INFUSION ISSUE 3 0.0012
243 RETINAL ARTERY OCCLUSION 3 0.0012
244 SHOULDER OPERATION 5 0.0012
245 BLOOD CHLORIDE INCREASED 2 0.0012
246 DERMATITIS ACNEIFORM 7 0.0011
247 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
248 OTORRHOEA 2 0.0011
249 CHRONIC KIDNEY DISEASE 87 0.0011
250 PARONYCHIA 5 0.0011
251 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
252 SWELLING OF EYELID 7 0.0011
253 SHOULDER ARTHROPLASTY 3 0.0011
254 ERYTHEMA OF EYELID 6 0.0011
255 EYE PRURITUS 37 0.0011
256 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
257 IMMUNE-MEDIATED MYOSITIS 3 0.0011
258 METAMORPHOPSIA 2 0.0011
259 RETINOPATHY 4 0.0011
260 PROTEIN TOTAL DECREASED 4 0.0011
261 PERIORBITAL SWELLING 6 0.0011
262 HYPOPROTEINAEMIA 2 0.0011
263 HEART VALVE INCOMPETENCE 3 0.0010
264 OSTEOPOROTIC FRACTURE 2 0.0010
265 RETINAL VEIN OCCLUSION 3 0.0010
266 LUMBAR SPINAL STENOSIS 3 0.0010
267 BLEPHARITIS 4 0.0010
268 DRY EYE 48 0.0010
269 LATENT TUBERCULOSIS 2 0.0010
270 INFUSION SITE PRURITUS 3 0.0009
271 EYELID OEDEMA 11 0.0009
272 ANAEMIA MACROCYTIC 2 0.0009
273 SKIN EROSION 3 0.0009
274 PRODUCT DELIVERY MECHANISM ISSUE 5 0.0009
275 DEAFNESS NEUROSENSORY 3 0.0009
276 LIMB MASS 2 0.0009
277 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
278 BACTERIAL TEST POSITIVE 2 0.0009
279 PRODUCT USE COMPLAINT 14 0.0009
280 URINARY TRACT DISORDER 4 0.0009
281 ENTEROCOLITIS 5 0.0009
282 STRESS CARDIOMYOPATHY 5 0.0009
283 MACULOPATHY 3 0.0008
284 SARCOIDOSIS 4 0.0008
285 CONJUNCTIVAL HYPERAEMIA 3 0.0008
286 MYOPIA 2 0.0008
287 MACULAR DEGENERATION 10 0.0008
288 SCLERODERMA 3 0.0008
289 SPONDYLITIS 3 0.0008
290 AUTOIMMUNE DISORDER 8 0.0008
291 RENAL CELL CARCINOMA 4 0.0008
292 DERMAL CYST 2 0.0008
293 PIGMENTATION DISORDER 5 0.0008
294 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
295 BLOOD CALCIUM INCREASED 7 0.0008
296 REBOUND EFFECT 9 0.0008
297 PHOTOPSIA 5 0.0008
298 TREATMENT FAILURE 65 0.0008
299 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
300 NOCARDIOSIS 2 0.0008
301 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
302 MUSCLE RUPTURE 3 0.0008
303 POLYP 5 0.0008
304 SENSITIVITY TO WEATHER CHANGE 4 0.0008
305 FRUSTRATION TOLERANCE DECREASED 6 0.0007
306 PRODUCT LABEL ISSUE 5 0.0007
307 PRODUCT PACKAGING ISSUE 7 0.0007
308 SPINAL COMPRESSION FRACTURE 6 0.0007
309 HYPERKERATOSIS 4 0.0007
310 STREPTOCOCCAL INFECTION 4 0.0007
311 ABSCESS LIMB 3 0.0007
312 RHEUMATOID FACTOR POSITIVE 4 0.0007
313 EYELID MARGIN CRUSTING 2 0.0007
314 POST PROCEDURAL COMPLICATION 13 0.0007
315 HEPATITIS FULMINANT 2 0.0007
316 FACIAL PAIN 6 0.0007
317 PAPILLOEDEMA 3 0.0007
318 SUSPECTED OFF LABEL USE 3 0.0007
319 ADRENAL INSUFFICIENCY 8 0.0007
320 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
321 IRON DEFICIENCY ANAEMIA 6 0.0006
322 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
323 FOOD ALLERGY 5 0.0006
324 ERYTHEMA MULTIFORME 6 0.0006
325 SCAR 11 0.0006
326 PRE-EXISTING CONDITION IMPROVED 4 0.0006
327 SEASONAL ALLERGY 9 0.0006
328 DRUG EFFECT INCREASED 2 0.0006
329 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
330 FURUNCLE 5 0.0006
331 MEDICATION RESIDUE PRESENT 3 0.0006
332 ORAL PAIN 14 0.0006
333 TRANSPLANT REJECTION 5 0.0006
334 POST PROCEDURAL INFECTION 5 0.0006
335 NEAR DEATH EXPERIENCE 2 0.0006
336 PROTEIN URINE PRESENT 3 0.0006
337 INFLAMMATION 31 0.0006
338 POST-TRAUMATIC STRESS DISORDER 4 0.0006
339 INFUSION SITE ERYTHEMA 5 0.0006
340 SINUS CONGESTION 8 0.0006
341 CARBOHYDRATE ANTIGEN 125 INCREASED 2 0.0006
342 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
343 VITAMIN D DECREASED 5 0.0006
344 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
345 LARGE INTESTINE POLYP 4 0.0006
346 EXPIRED PRODUCT ADMINISTERED 19 0.0006
347 GENERALISED OEDEMA 7 0.0006
348 HAND FRACTURE 4 0.0006
349 STRESS FRACTURE 3 0.0006
350 FACIAL BONES FRACTURE 2 0.0006
351 OPTIC NEURITIS 5 0.0005
352 NEPHROPATHY 5 0.0005
353 PRODUCT LEAKAGE 3 0.0005
354 PARANOIA 9 0.0005
355 MOUTH ULCERATION 11 0.0005
356 BLOOD URIC ACID INCREASED 3 0.0005
357 PELVIC FRACTURE 4 0.0005
358 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
359 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
360 NAIL DISCOLOURATION 2 0.0005
361 DRUG ERUPTION 9 0.0005
362 BLOOD ALBUMIN DECREASED 4 0.0005
363 TYPE 1 DIABETES MELLITUS 3 0.0005
364 HIP FRACTURE 16 0.0005
365 STENT PLACEMENT 4 0.0005
366 EYELID PTOSIS 5 0.0005
367 RASH PAPULAR 11 0.0005
368 MENISCUS INJURY 3 0.0005
369 ARTHRITIS BACTERIAL 2 0.0005
370 ANAPHYLACTOID REACTION 2 0.0005
371 CHOLANGITIS 3 0.0005
372 DERMATITIS 10 0.0005
373 INFUSION SITE SWELLING 3 0.0005
374 ONYCHOMADESIS 2 0.0005
375 JOINT DISLOCATION 5 0.0005
376 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
377 HORDEOLUM 2 0.0005
378 PYELONEPHRITIS 4 0.0005
379 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
380 TUMOUR LYSIS SYNDROME 4 0.0005
381 IMMUNOSUPPRESSION 4 0.0005
382 LIGAMENT RUPTURE 2 0.0005
383 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
384 STEVENS-JOHNSON SYNDROME 10 0.0004
385 TRANSAMINASES INCREASED 10 0.0004
386 NERVE INJURY 5 0.0004
387 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
388 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
389 RENAL FAILURE 58 0.0004
390 LUMBAR VERTEBRAL FRACTURE 2 0.0004
391 MOVEMENT DISORDER 14 0.0004
392 CONJUNCTIVITIS 8 0.0004
393 DEFORMITY 4 0.0004
394 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
395 BLOOD IRON DECREASED 5 0.0004
396 LIVER FUNCTION TEST INCREASED 9 0.0004
397 ACCIDENT 5 0.0004
398 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
399 CANDIDA INFECTION 7 0.0004
400 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
401 ENCEPHALOPATHY 10 0.0004
402 NASAL POLYPS 2 0.0004
403 DEVICE DEFECTIVE 7 0.0004
404 ANEURYSM 2 0.0004
405 HYPERNATRAEMIA 2 0.0004
406 ACUTE KIDNEY INJURY 60 0.0004
407 AMMONIA INCREASED 2 0.0004
408 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
409 TEMPERATURE INTOLERANCE 4 0.0004
410 CONCUSSION 3 0.0004
411 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
412 OSTEOMYELITIS 7 0.0004
413 HYPOALBUMINAEMIA 3 0.0004
414 HERPES ZOSTER 22 0.0004
415 SCIATICA 6 0.0004
416 JOINT INJURY 8 0.0004
417 BLISTER 21 0.0004
418 COMPRESSION FRACTURE 2 0.0004
419 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
420 HYPOACUSIS 16 0.0004
421 GINGIVITIS 2 0.0004
422 DECUBITUS ULCER 3 0.0004
423 SKIN LACERATION 4 0.0004
424 MUSCULOSKELETAL STIFFNESS 32 0.0004
425 HYPERAESTHESIA 3 0.0004
426 PHOTOSENSITIVITY REACTION 6 0.0004
427 DEAFNESS UNILATERAL 2 0.0004
428 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
429 GAIT INABILITY 12 0.0004
430 HEART RATE ABNORMAL 2 0.0004
431 INTESTINAL PERFORATION 4 0.0004
432 SCAB 4 0.0004
433 PSEUDOMONAS INFECTION 3 0.0003
434 SKIN HYPERPIGMENTATION 3 0.0003
435 HERPES VIRUS INFECTION 2 0.0003
436 DIPLOPIA 9 0.0003
437 PRODUCT QUALITY ISSUE 47 0.0003
438 SPINAL OSTEOARTHRITIS 3 0.0003
439 SPLENOMEGALY 4 0.0003
440 NIGHT SWEATS 11 0.0003
441 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
442 SKIN HAEMORRHAGE 5 0.0003
443 PRODUCT DOSE OMISSION 22 0.0003
444 GOUT 6 0.0003
445 TOOTHACHE 6 0.0003
446 PNEUMONITIS 9 0.0003
447 ECONOMIC PROBLEM 5 0.0003
448 RHINORRHOEA 21 0.0003
449 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
450 EPISTAXIS 24 0.0003
451 FLANK PAIN 3 0.0003
452 SECRETION DISCHARGE 4 0.0003
453 NASAL DRYNESS 2 0.0003
454 NEUTROPHIL COUNT DECREASED 13 0.0003
455 ARTERIOSCLEROSIS 3 0.0003
456 LEUKAEMIA 3 0.0003
457 SPUTUM DISCOLOURED 3 0.0003
458 NO ADVERSE EVENT 57 0.0003
459 RECALLED PRODUCT ADMINISTERED 3 0.0003
460 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
461 SNEEZING 7 0.0003
462 MYDRIASIS 4 0.0003
463 THERAPY NON-RESPONDER 14 0.0003
464 CHROMATURIA 7 0.0003
465 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
466 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
467 BRADYPHRENIA 2 0.0003
468 KNEE OPERATION 3 0.0003
469 ASPERGILLUS INFECTION 2 0.0003
470 DYSGRAPHIA 2 0.0003
471 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
472 DRUG INTOLERANCE 29 0.0003
473 BLOOD POTASSIUM DECREASED 9 0.0003
474 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
475 TOXIC SKIN ERUPTION 3 0.0003
476 FULL BLOOD COUNT DECREASED 6 0.0003
477 STOMATITIS 18 0.0003
478 DRY THROAT 3 0.0003
479 LIMB INJURY 8 0.0003
480 MOTOR DYSFUNCTION 3 0.0003
481 EYE MOVEMENT DISORDER 2 0.0003
482 SWELLING FACE 19 0.0003
483 ONYCHOCLASIS 2 0.0003
484 HAIR GROWTH ABNORMAL 2 0.0003
485 FIBROMYALGIA 7 0.0003
486 HYPERTRANSAMINASAEMIA 2 0.0003
487 HYPOMAGNESAEMIA 4 0.0003
488 WEIGHT FLUCTUATION 3 0.0003
489 CEREBRAL INFARCTION 7 0.0003
490 TRANSFUSION 3 0.0003
491 DEVICE USE ISSUE 5 0.0003
492 NEPHROLITHIASIS 13 0.0003
493 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
494 THERAPY INTERRUPTED 20 0.0003
495 DECREASED ACTIVITY 3 0.0003
496 BACK INJURY 3 0.0003
497 RESTLESS LEGS SYNDROME 5 0.0003
498 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
499 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
500 RENAL INJURY 8 0.0003
501 SKIN INFECTION 3 0.0003
502 NEPHROPATHY TOXIC 3 0.0003
503 ARTHRITIS 21 0.0003
504 JOINT STIFFNESS 7 0.0003
505 ANHEDONIA 7 0.0003
506 HEART RATE IRREGULAR 6 0.0003
507 IMPAIRED DRIVING ABILITY 3 0.0003
508 OSTEOPENIA 4 0.0003
509 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
510 DERMATITIS CONTACT 3 0.0003
511 MUSCULOSKELETAL DISORDER 5 0.0003
512 MICTURITION URGENCY 3 0.0003
513 SLEEP APNOEA SYNDROME 5 0.0003
514 BLOOD PRESSURE INCREASED 40 0.0003
515 FALL 87 0.0003
516 LOWER LIMB FRACTURE 5 0.0003
517 ACUTE RESPIRATORY FAILURE 5 0.0003
518 DEVICE RELATED INFECTION 4 0.0003
519 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
520 OSTEOARTHRITIS 11 0.0003
521 PRODUCT DOSE OMISSION ISSUE 76 0.0003
522 ANKLE FRACTURE 4 0.0003
523 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
524 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
525 EJECTION FRACTION DECREASED 4 0.0003
526 COVID-19 45 0.0003
527 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
528 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
529 HOT FLUSH 19 0.0003
530 RESPIRATORY TRACT CONGESTION 4 0.0003
531 BLOOD PRESSURE ABNORMAL 5 0.0003
532 ACNE 19 0.0003
533 NECK PAIN 14 0.0003
534 DEMENTIA 7 0.0003
535 CONDITION AGGRAVATED 76 0.0002
536 DIABETIC KETOACIDOSIS 6 0.0002
537 SPINAL FRACTURE 5 0.0002
538 NERVOUSNESS 13 0.0002
539 MYASTHENIA GRAVIS 2 0.0002
540 BURSITIS 3 0.0002
541 NOCTURIA 3 0.0002
542 PLEURAL EFFUSION 15 0.0002
543 TASTE DISORDER 5 0.0002
544 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
545 HYPERSOMNIA 7 0.0002
546 PHARYNGITIS 3 0.0002
547 BLOOD PRESSURE DECREASED 16 0.0002
548 CELLULITIS 12 0.0002
549 TREATMENT NONCOMPLIANCE 13 0.0002
550 FACIAL PARALYSIS 2 0.0002
551 DRY MOUTH 19 0.0002
552 INFUSION SITE PAIN 3 0.0002
553 SKIN ULCER 6 0.0002
554 HIATUS HERNIA 3 0.0002
555 CARDIAC MURMUR 2 0.0002
556 INFLUENZA LIKE ILLNESS 19 0.0002
557 URINARY TRACT INFECTION 39 0.0002
558 ORAL CANDIDIASIS 3 0.0002
559 IMMUNE SYSTEM DISORDER 3 0.0002
560 INTERSTITIAL LUNG DISEASE 11 0.0002
561 LYMPHOCYTE COUNT DECREASED 4 0.0002
562 BRADYCARDIA 12 0.0002
563 LYMPHADENOPATHY 8 0.0002
564 SKIN EXFOLIATION 19 0.0002
565 DEPRESSION 51 0.0002
566 MYOSITIS 2 0.0002
567 PALPITATIONS 26 0.0002
568 DEVICE BREAKAGE 9 0.0002
569 NASAL CONGESTION 13 0.0002
570 HEAD INJURY 7 0.0002
571 LEUKOCYTOSIS 4 0.0002
572 IMPAIRED GASTRIC EMPTYING 3 0.0002
573 ACCIDENTAL OVERDOSE 8 0.0002
574 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
575 CONTUSION 21 0.0002
576 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
577 INCREASED TENDENCY TO BRUISE 2 0.0002
578 MENTAL STATUS CHANGES 6 0.0002
579 ORAL DISCOMFORT 3 0.0002
580 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
581 SINUSITIS 22 0.0002
582 CARPAL TUNNEL SYNDROME 3 0.0002
583 APPENDICITIS 2 0.0002
584 BLOOD TEST ABNORMAL 3 0.0002
585 LACERATION 2 0.0002
586 HALLUCINATION 16 0.0002
587 HEART RATE INCREASED 21 0.0002
588 COUGH 59 0.0002
589 INCORRECT DOSE ADMINISTERED 48 0.0002
590 WEIGHT INCREASED 47 0.0002
591 SKIN DISORDER 7 0.0002
592 RED BLOOD CELL COUNT DECREASED 6 0.0002
593 URINARY RETENTION 7 0.0002
594 PARALYSIS 3 0.0002
595 MIGRAINE 20 0.0002
596 IMPAIRED QUALITY OF LIFE 3 0.0002
597 DEVICE DISLOCATION 9 0.0002
598 ATELECTASIS 2 0.0002
599 OROPHARYNGEAL PAIN 19 0.0002
600 SKIN FISSURES 4 0.0002
601 DRUG EFFECT DECREASED 11 0.0002
602 ILLNESS 21 0.0002
603 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
604 HEPATOMEGALY 2 0.0002
605 PSYCHOTIC DISORDER 6 0.0002
606 RASH PRURITIC 11 0.0002
607 OEDEMA 11 0.0002
608 URINARY INCONTINENCE 6 0.0002
609 OFF LABEL USE 177 0.0002
610 SINUS DISORDER 4 0.0002
611 DYSGEUSIA 15 0.0002
612 DELIRIUM 7 0.0002
613 HEADACHE 126 0.0002
614 HAEMORRHAGE INTRACRANIAL 3 0.0002
615 JOINT SWELLING 24 0.0002
616 HYPOXIA 7 0.0002
617 APHASIA 6 0.0002
618 PRODUCT PHYSICAL ISSUE 4 0.0002
619 BACK PAIN 46 0.0002
620 DIABETES MELLITUS 15 0.0002
621 INJURY ASSOCIATED WITH DEVICE 4 0.0002
622 SKIN DISCOLOURATION 9 0.0002
623 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
624 NEUTROPHIL COUNT INCREASED 2 0.0002
625 INITIAL INSOMNIA 2 0.0002
626 EAR DISCOMFORT 2 0.0002
627 THERAPY CESSATION 10 0.0002
628 PERIPHERAL SWELLING 30 0.0002
629 OSTEOPOROSIS 8 0.0002
630 HYPERSENSITIVITY 36 0.0002
631 LIMB DISCOMFORT 6 0.0002
632 TENDONITIS 3 0.0002
633 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
634 LUNG INFECTION 3 0.0002
635 SWELLING 18 0.0002
636 SWOLLEN TONGUE 6 0.0002
637 POLLAKIURIA 8 0.0002
638 BONE DENSITY DECREASED 6 0.0002
639 DRUG INEFFECTIVE 251 0.0002
640 DYSURIA 7 0.0002
641 PRURITUS 73 0.0002
642 DYSPHAGIA 18 0.0002
643 INCONTINENCE 2 0.0002
644 BRONCHITIS 14 0.0002
645 ULCER 3 0.0002
646 HEPATIC FUNCTION ABNORMAL 7 0.0002
647 HEREDITARY ANGIOEDEMA 2 0.0002
648 WHEEZING 11 0.0002
649 DECREASED APPETITE 43 0.0002
650 THROAT TIGHTNESS 5 0.0002
651 BLOOD POTASSIUM INCREASED 3 0.0002
652 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
653 OESOPHAGITIS 2 0.0002
654 CHOLELITHIASIS 6 0.0002
655 METASTASES TO BONE 3 0.0002
656 MEMORY IMPAIRMENT 25 0.0002
657 PROCEDURAL PAIN 5 0.0002
658 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
659 INFECTION 26 0.0002
660 NEUROPATHY PERIPHERAL 17 0.0002
661 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
662 THROAT IRRITATION 8 0.0002
663 FACE OEDEMA 3 0.0002
664 MUSCULAR WEAKNESS 20 0.0002
665 ERYTHEMA 36 0.0002
666 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
667 RASH 76 0.0002
668 MUSCULOSKELETAL DISCOMFORT 3 0.0002
669 TINNITUS 8 0.0002
670 BALANCE DISORDER 15 0.0002
671 FATIGUE 135 0.0002
672 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
673 PERICARDIAL EFFUSION 4 0.0002
674 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
675 OEDEMA PERIPHERAL 21 0.0002
676 ORTHOSTATIC HYPOTENSION 3 0.0002
677 LOCAL SWELLING 3 0.0002
678 NEEDLE ISSUE 5 0.0002
679 ARTHRALGIA 71 0.0002
680 METASTASES TO LIVER 3 0.0002
681 SURGERY 10 0.0002
682 SLEEP DISORDER 12 0.0002
683 BACTERAEMIA 2 0.0002
684 BLOOD CREATININE INCREASED 11 0.0002
685 CHEST PAIN 31 0.0002
686 HYPERLIPIDAEMIA 2 0.0002
687 RESPIRATORY DISORDER 5 0.0002
688 ABDOMINAL DISCOMFORT 28 0.0002
689 BLOOD PRESSURE FLUCTUATION 4 0.0002
690 HEPATIC FAILURE 5 0.0002
691 CORONARY ARTERY DISEASE 5 0.0002
692 C-REACTIVE PROTEIN INCREASED 6 0.0002
693 LIVER INJURY 4 0.0002
694 CARDIOMEGALY 2 0.0002
695 ARTHROPATHY 9 0.0002
696 ANXIETY 46 0.0002
697 INFLUENZA 18 0.0002
698 HEPATIC ENZYME INCREASED 11 0.0002
699 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
700 SEPTIC SHOCK 7 0.0002
701 BACTERIAL INFECTION 3 0.0002
702 APPLICATION SITE IRRITATION 2 0.0002
703 MIDDLE INSOMNIA 3 0.0002
704 AGEUSIA 4 0.0002
705 LEUKOPENIA 8 0.0002
706 HYPOCALCAEMIA 3 0.0002
707 FRACTURE 3 0.0002
708 FOOT FRACTURE 3 0.0002
709 MUSCLE ATROPHY 2 0.0002
710 HYPOTHYROIDISM 5 0.0002
711 PYREXIA 54 0.0002
712 HAEMOGLOBIN DECREASED 16 0.0002
713 DRUG RESISTANCE 4 0.0002
714 PRESCRIBED OVERDOSE 3 0.0002
715 DIARRHOEA 100 0.0002
716 RENAL IMPAIRMENT 13 0.0002
717 RASH GENERALISED 4 0.0002
718 PNEUMONIA 50 0.0002
719 INJECTION SITE INDURATION 2 0.0002
720 HAEMORRHOIDS 3 0.0002
721 NODULE 2 0.0002
722 DEAFNESS 4 0.0002
723 MYALGIA 26 0.0002
724 IMPAIRED HEALING 5 0.0002
725 ANKYLOSING SPONDYLITIS 2 0.0002
726 UPPER LIMB FRACTURE 3 0.0002
727 MALAISE 66 0.0002
728 PRESCRIBED UNDERDOSE 3 0.0002
729 RENAL DISORDER 7 0.0002
730 BLOOD CHOLESTEROL INCREASED 7 0.0002
731 PLATELET COUNT DECREASED 16 0.0001
732 FUNGAL INFECTION 5 0.0001
733 DEHYDRATION 20 0.0001
734 AGITATION 11 0.0001
735 HAIR TEXTURE ABNORMAL 2 0.0001
736 CARDIAC FAILURE 12 0.0001
737 PRODUCT USE IN UNAPPROVED INDICATION 37 0.0001
738 MALIGNANT MELANOMA 2 0.0001
739 URTICARIA 25 0.0001
740 JOINT RANGE OF MOTION DECREASED 2 0.0001
741 PAIN OF SKIN 4 0.0001
742 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
743 FEEDING DISORDER 3 0.0001
744 DYSKINESIA 6 0.0001
745 DISEASE RECURRENCE 7 0.0001
746 PRODUCTIVE COUGH 7 0.0001
747 CHEST DISCOMFORT 15 0.0001
748 NASOPHARYNGITIS 27 0.0001
749 GINGIVAL BLEEDING 2 0.0001
750 HYPERTENSION 31 0.0001
751 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
752 DEVICE ISSUE 13 0.0001
753 HAEMATOCHEZIA 8 0.0001
754 RESPIRATORY DISTRESS 4 0.0001
755 PAIN 89 0.0001
756 ANAPHYLACTIC REACTION 8 0.0001
757 DIVERTICULITIS 4 0.0001
758 BLOOD GLUCOSE INCREASED 27 0.0001
759 WOUND 4 0.0001
760 MASS 2 0.0001
761 BURNING SENSATION 10 0.0001
762 HYPERKALAEMIA 5 0.0001
763 KNEE ARTHROPLASTY 3 0.0001
764 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
765 HYPONATRAEMIA 8 0.0001
766 BRONCHOSPASM 2 0.0001
767 PARAESTHESIA 22 0.0001
768 PRURITUS GENERALISED 3 0.0001
769 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
770 FAECES DISCOLOURED 3 0.0001
771 PRODUCT USE ISSUE 26 0.0001
772 INJECTION SITE BRUISING 11 0.0001
773 FLUSHING 14 0.0001
774 FLUID RETENTION 7 0.0001
775 CONSTIPATION 30 0.0001
776 LIVER FUNCTION TEST ABNORMAL 4 0.0001
777 ALOPECIA 27 0.0001
778 HYPERGLYCAEMIA 5 0.0001
779 GASTROENTERITIS 2 0.0001
780 CARDIAC FAILURE CONGESTIVE 11 0.0001
781 BONE PAIN 8 0.0001
782 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
783 DIZZINESS 68 0.0001
784 FEBRILE NEUTROPENIA 9 0.0001
785 DISEASE PROGRESSION 16 0.0001
786 INSOMNIA 36 0.0001
787 TOOTH DISORDER 3 0.0001
788 IMMUNODEFICIENCY 2 0.0001
789 GLOSSODYNIA 3 0.0001
790 PANCREATITIS ACUTE 3 0.0001
791 LOSS OF CONSCIOUSNESS 17 0.0001
792 HYPOAESTHESIA ORAL 2 0.0001
793 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
794 HYPERHIDROSIS 17 0.0001
795 GAIT DISTURBANCE 25 0.0001
796 FEELING HOT 8 0.0001
797 DRUG ADMINISTRATION ERROR 4 0.0001
798 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
799 MUSCLE TWITCHING 3 0.0001
800 HYPOKALAEMIA 6 0.0001
801 FEMUR FRACTURE 4 0.0001
802 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
803 BASAL CELL CARCINOMA 2 0.0001
804 PLASMA CELL MYELOMA 5 0.0001
805 DRUG-INDUCED LIVER INJURY 4 0.0001
806 HYPOAESTHESIA 19 0.0001
807 HALLUCINATION, AUDITORY 2 0.0001
808 INTENTIONAL PRODUCT MISUSE 11 0.0001
809 CYSTITIS 4 0.0001
810 MUSCLE SPASMS 23 0.0001
811 FEELING ABNORMAL 30 0.0001
812 METABOLIC ACIDOSIS 4 0.0001
813 HYPOTENSION 25 0.0001
814 EMOTIONAL DISTRESS 15 0.0001
815 MUSCLE TIGHTNESS 2 0.0001
816 NEURALGIA 3 0.0001
817 RHEUMATOID ARTHRITIS 14 0.0001
818 ATRIAL FIBRILLATION 12 0.0001
819 PSORIATIC ARTHROPATHY 5 0.0001
820 PAIN IN EXTREMITY 36 0.0001
821 WEIGHT DECREASED 34 0.0001
822 MULTIPLE FRACTURES 2 0.0001
823 LUNG NEOPLASM MALIGNANT 5 0.0001
824 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
825 ANAEMIA 23 0.0001
826 CYTOMEGALOVIRUS INFECTION 2 0.0001
827 NEOPLASM MALIGNANT 8 0.0001
828 BLOOD UREA INCREASED 2 0.0001
829 ABDOMINAL PAIN LOWER 3 0.0001
830 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
831 GASTRIC CANCER 3 0.0001
832 HYPOPHAGIA 3 0.0001
833 HAEMATURIA 4 0.0001
834 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
835 SEPSIS 13 0.0001
836 HAEMATOMA 3 0.0001
837 THERAPEUTIC RESPONSE DECREASED 7 0.0001
838 ILL-DEFINED DISORDER 7 0.0001
839 RESPIRATORY TRACT INFECTION 3 0.0001
840 DRUG DOSE OMISSION 19 0.0001
841 DISCOMFORT 7 0.0001
842 MUSCULOSKELETAL PAIN 6 0.0001
843 ASTHENIA 43 0.0001
844 GASTRITIS 3 0.0001
845 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
846 DYSPNOEA 64 0.0001
847 HEAD DISCOMFORT 2 0.0001
848 LIVER DISORDER 5 0.0001
849 CEREBROVASCULAR ACCIDENT 19 0.0001
850 CEREBRAL HAEMORRHAGE 4 0.0001
851 FEAR 3 0.0001
852 BLOOD BILIRUBIN INCREASED 3 0.0001
853 CHILLS 13 0.0001
854 GASTROENTERITIS VIRAL 2 0.0001
855 HOSPITALISATION 17 0.0001
856 DRUG EFFECT INCOMPLETE 4 0.0001
857 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
858 MOOD ALTERED 3 0.0001
859 PANIC ATTACK 4 0.0001
860 BLOOD GLUCOSE ABNORMAL 2 0.0001
861 AMNESIA 7 0.0001
862 HAEMOPTYSIS 3 0.0001
863 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
864 NAUSEA 85 0.0001
865 HEPATIC STEATOSIS 2 0.0001
866 COGNITIVE DISORDER 5 0.0001
867 CARDIAC DISORDER 10 0.0001
868 DYSARTHRIA 4 0.0001
869 ASTHMA 12 0.0001
870 INTESTINAL OBSTRUCTION 4 0.0001
871 PAIN IN JAW 3 0.0001
872 BLOOD URINE PRESENT 2 0.0001
873 INTENTIONAL DOSE OMISSION 3 0.0001
874 ANGINA PECTORIS 3 0.0001
875 INJECTION SITE PAIN 32 0.0001
876 VOMITING 49 0.0001
877 PRODUCT SUBSTITUTION ISSUE 6 0.0001
878 DRUG PRESCRIBING ERROR 2 0.0001
879 EAR PAIN 2 0.0001
880 PRODUCT STORAGE ERROR 9 0.0001
881 DYSSTASIA 3 0.0001
882 CHOKING 2 0.0001
883 ORAL HERPES 2 0.0001
884 TREMOR 17 0.0001
885 ASCITES 3 0.0001
886 LUNG DISORDER 5 0.0001
887 KIDNEY INFECTION 2 0.0001
888 ACUTE MYOCARDIAL INFARCTION 3 0.0001
889 LABORATORY TEST ABNORMAL 3 0.0001
890 ADVERSE DRUG REACTION 9 0.0001
891 INJECTION SITE HAEMORRHAGE 8 0.0001
892 CYTOKINE RELEASE SYNDROME 2 0.0001
893 SOMNOLENCE 20 0.0001
894 EPILEPSY 3 0.0001
895 DRY SKIN 13 0.0001
896 EMOTIONAL DISORDER 3 0.0001
897 CARDIO-RESPIRATORY ARREST 4 0.0001
898 PANCREATITIS 5 0.0001
899 MOOD SWINGS 3 0.0001
900 EATING DISORDER 2 0.0001
901 UNEVALUABLE EVENT 7 0.0001
902 DEEP VEIN THROMBOSIS 6 0.0001
903 ABDOMINAL PAIN UPPER 19 0.0001
904 PSORIASIS 12 0.0001
905 STAPHYLOCOCCAL INFECTION 3 0.0001
906 MELAENA 2 0.0001
907 VIRAL INFECTION 3 0.0001
908 MEDICATION ERROR 5 0.0001
909 OXYGEN SATURATION DECREASED 5 0.0001
910 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
911 ANGER 3 0.0001
912 FLATULENCE 5 0.0001
913 LETHARGY 5 0.0001
914 NIGHTMARE 3 0.0001
915 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
916 PULMONARY EMBOLISM 8 0.0001
917 BLOOD GLUCOSE DECREASED 4 0.0001
918 IRRITABILITY 5 0.0001
919 NEUTROPENIA 11 0.0001
920 OSTEONECROSIS OF JAW 2 0.0001
921 THROMBOCYTOPENIA 9 0.0001
922 SYNCOPE 8 0.0001
923 DYSPNOEA EXERTIONAL 3 0.0001
924 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
925 COLITIS 3 0.0001
926 DEATH 68 0.0001
927 HAEMATEMESIS 2 0.0001
928 CARDIOVASCULAR DISORDER 2 0.0001
929 INJECTION SITE SWELLING 6 0.0001
930 GASTROINTESTINAL DISORDER 7 0.0001
931 DERMATITIS ATOPIC 4 0.0001
932 ABNORMAL BEHAVIOUR 3 0.0001
933 DEPRESSED MOOD 4 0.0001
934 EAR INFECTION 2 0.0001
935 INJECTION SITE PRURITUS 5 0.0001
936 EXTRA DOSE ADMINISTERED 3 0.0001
937 INJECTION SITE REACTION 5 0.0001
938 INJECTION SITE ERYTHEMA 9 0.0001
939 ABNORMAL DREAMS 2 0.0001
940 FEELING COLD 2 0.0001
941 PANCYTOPENIA 4 0.0001
942 INJURY 5 0.0001
943 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
944 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
945 RECTAL HAEMORRHAGE 3 0.0001
946 SKIN BURNING SENSATION 5 0.0001
947 SEIZURE 8 0.0001
948 RESPIRATORY FAILURE 5 0.0001
949 UNDERDOSE 5 0.0001
950 DYSPHONIA 4 0.0001
951 CONFUSIONAL STATE 11 0.0001
952 COLITIS ULCERATIVE 3 0.0001
953 RASH ERYTHEMATOUS 3 0.0001
954 MULTIPLE SCLEROSIS 3 0.0001
955 LACTIC ACIDOSIS 2 0.0001
956 DYSPEPSIA 6 0.0001
957 CARDIAC ARREST 5 0.0001
958 INFUSION RELATED REACTION 4 0.0001
959 ABDOMINAL PAIN 14 0.0001
960 LIP SWELLING 2 0.0001
961 NEOPLASM PROGRESSION 2 0.0001
962 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
963 ABDOMINAL DISTENSION 6 0.0001
964 HAEMORRHAGE 6 0.0001
965 ECZEMA 3 0.0001
966 MYOCARDIAL INFARCTION 10 0.0001
967 SPEECH DISORDER 3 0.0001
968 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
969 MOBILITY DECREASED 4 0.0001
970 DISTURBANCE IN ATTENTION 3 0.0001
971 MYELOSUPPRESSION 2 0.0001
972 ADVERSE EVENT 5 0.0001
973 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
974 DISORIENTATION 2 0.0001
975 PROSTATE CANCER 4 0.0000
976 THROMBOSIS 4 0.0000
977 VERTIGO 3 0.0000
978 OVERDOSE 10 0.0000
979 MENTAL DISORDER 2 0.0000
980 DEVICE DIFFICULT TO USE 3 0.0000
981 TACHYCARDIA 4 0.0000
982 DEVICE MALFUNCTION 3 0.0000
983 ARRHYTHMIA 2 0.0000
984 COMA 2 0.0000
985 HYPOGLYCAEMIA 2 0.0000
986 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
987 DRUG INTERACTION 5 0.0000
988 TOXICITY TO VARIOUS AGENTS 5 0.0000
989 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
990 DRUG DEPENDENCE 3 0.0000